首页> 外文期刊>Clinical immunology: The official journal of the Clinical Immunology Society >Coexpression of normal and mutated CD40 ligand with deletion of a putative RNA lariat branchpoint sequence in X-linked hyper-IgM syndrome.
【24h】

Coexpression of normal and mutated CD40 ligand with deletion of a putative RNA lariat branchpoint sequence in X-linked hyper-IgM syndrome.

机译:正常和突变的CD40配体在X连锁的超IgM综合征中的共表达与假定的RNA套索分支点缺失的共表达。

获取原文
获取原文并翻译 | 示例
           

摘要

We describe a novel CD40 ligand (CD40L) splicing mutation in a patient with X-linked hyper-IgM syndrome (X-HIM) associated with alternate splicing of exon 3, resulting in the expression of both full-length and exon-3-skipped CD40L mRNA. The mutation is an 8-bp deletion 25 bp upstream of the intron 2/exon 3 junction which overlaps a putative RNA branchpoint, suggesting that it may impair RNA lariat formation. The exon-3-skipped CD40L transcript encodes a truncated protein (CD40LDeltaE3) encompassing the cytoplasmic, transmembrane, and extracellular stalk domains, but lacking the CD40L receptor binding domain. CD40LDeltaE3 protein expression was readily detectable in transfected Cos cells by immunofluorescence. In cells cotransfected with CD40LDeltaE3 and wild-type CD40L, expression of CD40LDeltaE3 did not inhibit the expression of wild-type CD40L monomers, but strongly inhibited staining by the conformationally sensitive anti-CD40L mAb 5c8, suggesting that CD40LDeltaE3 acts in a dominant negative manner to inhibit the assembly of functional CD40L trimers. This mechanism may contribute to the pathophysiology of CD40L deficiency in X-HIM patients with leaky splice site mutations. Copyright 2001 Academic Press.
机译:我们描述了一种新的CD40配体(CD40L)剪接突变与X连锁的超IgM综合征(X-HIM)的患者与外显子3的可变剪接相关,导致全长和外显子3跳过的表达CD40L mRNA。突变是内含子2 /外显子3接头上游25 bp的8 bp缺失,与假定的RNA分支点重叠,表明它可能会损害RNA套索的形成。外显子3跳过的CD40L转录本编码截短的蛋白(CD40LDeltaE3),该蛋白包含细胞质,跨膜和细胞外茎域,但缺少CD40L受体结合域。通过免疫荧光在转染的Cos细胞中很容易检测到CD40LDeltaE3蛋白表达。在用CD40LDeltaE3和野生型CD40L共转染的细胞中,CD40LDeltaE3的表达不会抑制野生型CD40L单体的表达,但会强烈抑制构象敏感的抗CD40L mAb 5c8的染色,表明CD40LDeltaE3以显性负性方式抑制功能性CD40L三聚体的组装。此机制可能有助于具有漏接位点突变的X-HIM患者CD40L缺乏的病理生理。版权所有2001,学术出版社。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号